[e-med] 2003 SEAM Conference

[remed@remed.org]

E-MED: 2003 SEAM Conference
---------------------------------------------------------------------

[Modérateur: voici le programme d'une conférence sur les politiques
pharmaceutiques en Afrique qui devrait réunir en Tanzanie la semaine plus de
400 participants (dont quelques francophones) et dont un des objectifs est
d'émettre des recommandations...CB]

« Cibler l?accès élargi, » le 10-12 Décembre 2003,
Dar es Salaam, République unie de Tanzanie
avec le Ministère de la Santé de la République unie de Tanzanie, le
Département des médicaments essentiels et politique pharmaceutique de l?
Organisation mondiale de la Santé, la Fondation Rockefeller, le Réseau
international pour l?utilisation rationnelle des médicaments (INRUD), et les
Programmes Rational Pharmaceutical Management Plus (financé par l?Agence des
Etats-Unis pour le Développement international) et SEAM de Management
Sciences for Health (MSH).

La Conférence 2003 assemblera les dépositaires principaux pour discuter des
manières d'avancer l'accès aux médecines essentielles dans les pays en voie
de développement, d'adresser les soucis de la fourniture pharmaceutique et
de l'évaluation, et d'assurer les systèmes de gestion pharmaceutiques
efficaces. La Conférence fournira également l'occasion de partager des
informations sur les activités de plusieurs initiatives de SEAM et d'autres
projets qui se concentrent sur l'accès croissant aux médecines essentielles.
La Conférence est particulièrement opportune à cause de plus grand
écoulement du fonds par le Fonds mondial de lutte contre le SIDA, la
tuberculose et le paludisme, comme d'autres efforts d'améliorer l'accès aux
médecines.

La conférence comportera des présentations plénières et des présentations
parallèles sur six matières principales, suivies des discussions en table
ronde pour chaque matière. Les présentations de posters pourvoiront une
occasion pour les participants présenter sur leurs initiatives, recherche,
et expérience.

website de la Conférence (www.msh.org/seam/conference)


Programme
Conference SEAM 2003

DAY 1?December 10, 2003

All Day
Posters and electronic demos on display
Author coverage during breaks

8:30?10:00 a.m.
Morning session #1
Plenary presentations ? Room: Kivukoni 1-3 (Simultaneous French translation
available)
·	Welcoming remarks
Jim Rankin, Management Sciences for Health, U.S.A.
·	Video message from the Bill & Melinda Gates Foundation
Dr. Richard D. Klausner, M.D., Executive Director, Global Health
·	Introduction of dignitaries
Dr. Gabriel Upunda, Chief Medical Officer, Ministry of Health, United
Republic of Tanzania
·	Commonwealth Regional Health Community remarks
Dr. Steven Shongwe, Regional Secretary, Commonwealth Regional Health
Community
·	Remarks by Representative of Health Ministers
To be announced
·	Rapid Expansion of Access to ARVs ? The Litmus Test of Drug Management for
the 21st Century
Dr. Jack Chow, Assistant Director-General, World Health Organization
·	Welcoming the Guest of Honor
Honorable Anna Margareth Abdallah, Minister of Health, United Republic of
Tanzania
·	Opening address
Amani Karume, President, Zanzibar, United Republic of Tanzania
·	Closing remarks
Jim Rankin, Management Sciences for Health, U.S.A.

10:00?10:30 a.m.
Coffee/Tea break

10:30 a.m.?12:30 p.m.
Morning session #2
Moderator: Jim Rankin, Management Sciences for Health, USA
Plenary presentations ? Room: Kivukoni 1-3 (Simultaneous French translation
available)
·	Overview of Pharmaceutical Access Issues in Developing Countries
Peter Mugyenyi, Joint Clinical Research Center, Uganda
·	The Mombasa Initiative: Developing and Implementing an Antiretroviral
Therapy Program in Kenya
Michael Thuo, Management Sciences for Health/RPM Plus, Nairobi, Kenya
·	Does the Public Sector Reach the Poor?
Ndola Prata, School of Public Health, University of California, Berkeley,
U.S.A.
·	The Role of the Private Sector in Public Supply of Medicines
Evan Lee and Denis Broun, Management Sciences for Health Europe,
Ferney-Voltaire, France
·	Discussion
12:30 p.m.?1:30 p.m.
Lunch break

1:30?3:30 p.m.
Afternoon session #1
Parallel track sessions
Pharmaceutical Management and Supply Systems ? Room: Kivukoni 4
Co-moderators: Margareth Ndomondo-Sigonda and Nancy Blum
1.	Public Health Supply Systems ? An Overview
Malcolm Clark, Management Sciences for Health/SEAM, U.S.A.
2.	Essential Drug Franchises
a.	Experience with Community Health Workers in Kenya
Liza Kimbo, SHEF, Kenya
b.	Developing a Chemical Sellers? Franchise in Ghana
Alex Banful, GSMF, Ghana
3.	Improving Access to Medicines in Rural Areas: The Tanzanian Experience
Romuald Mbwasi, SEAM/Tanzania
4.	Community Health Workers in Senegal Treat ARI with Co-trimoxazole
Emmanuel Wansi, BASICS II, U.S.A.
5.	Public Sector Supply in a Decentralized Environment: The Experience in
South Africa
Mandisa Hela, Ministry of Health, Department of Drugs, South Africa
6.	Pharmaceutical Industry Supply Initiatives: Lessons Learned
Sowedi Muyingo, Axios International

Rational Use of Medicines ? Room: Kivukoni 1-3 (Simultaneous French
translation available)
Co-moderators: Amos Massele and John Chalker
1.	Improving Use of Medicines in the Era of Expanding Access: Public and
Private Sector Approaches
Dennis Ross-Degnan, Harvard University, Boston, U.S.A.
2.	Evidence-Based Drug Decision Making: An International Collaborative
Framework
Gavin Steel, South Africa
3.	Current Approaches to Selection of Essential Drugs and Treatment
Guidelines: Indian Experiences
Sangeeta Sharma, Delhi Society for Promoting Rational Use of Drugs, India
4.	Community Drug Use Assessments: How Are They Done and How Useful Are They
in Promoting Rational Use of Medicines
a.	Community Drug Use Assessments: Methodological Issues in Design,
Implementation, and Using Results to Promote Rational Drug Use
Michael Gabra, Management Sciences for Health/RPM Plus, U.S.A.
b.	Community Drug Use Assessments: Experience from Senegal
Issa Diop, Ministry of Health, Central Medical Stores, Senegal
5.	Antimicrobial Resistance and Rational Use: The Challenges Ahead
Mohan Joshi, Management Sciences for Health/RPM Plus, U.S.A.
6.	Role of Regulatory Authorities in Promoting Rational Use of Drugs
Sauwakon Ratanawijitrasin, Chulalongkorn University, Thailand

3:30?4:00 p.m.
Coffee/Tea break

4:00?6:00 p.m.
Afternoon session #2
Small group discussions

 Pharmaceutical Management
and Supply Systems

Group A ? Room: Ruvu
Group B ? Room: Kivukoni 4
Group C ? Room: Marquee 3
Group D ? Room: Marquee 4
Rational Use of Medicines

Group A ? Room: Marquee 1
Group B ? Room: Marquee 2
Group C ? Room: Tradewinds
Group D ? Room: Kivukoni 1-3

DAY 2?December 11, 2003

All Day
Posters and electronic demos on display
Author coverage during breaks

8:30?10:00 a.m.
Morning session #1
Moderator: Gabriel Upunda
Plenary presentations ? Room: Kivukoni 1-3 (Simultaneous French translation
available)
·	The Evolving Role of Pharmaceutical Assessments: A USAID Perspective
Anthony Boni, USAID
·	Effective Drug Regulation in the Real World
Moderator: Lembit Rägo, WHO/EDM
·	Overview of the Issues
Sauwakon Ratanawijitrasin, Thailand
·	Developing Country Perspectives
o	Human and Financial Resources
Margareth Ndomondo-Sigonda, Food and Drugs Authority, Tanzania
o	Harmonization in the SADC Region: Challenges of Information Exchange
Precious Matsoso, Ministry of Health, Department of Drugs, South Africa
o	The Four P?s of Drug Product Quality
Benjamin Botwe, Food and Drugs Board, Ghana

10:00?10:30 a.m.
Coffee/Tea break

10:30 a.m.?12:30 p.m.
Morning session #2
Moderator: Gabriel Upunda
Plenary presentations ? Room: Kivukoni 1-3 (Simultaneous French translation
available)
·	Medicine Pricing: What?s Happening, and Where Do We Go from Here?
Jonathan Quick, WHO/EDM
·	Financing Drug Procurement: The Global Fund to Fight AIDS, Tuberculosis
and Malaria
Guido Bakker, GFATM, Switzerland
·	Monitoring Access to Essential Medicines
1.	The Developing Country Perspective and Experience
Joseph Serutoke, Uganda
2.	Measures and Methods
David Lee, Management Sciences for Health/CPM, U.S.A.
·	Discussion

12:30 p.m.?1:30 p.m.
Lunch break

1:30?3:30 p.m.
Afternoon session #1
Parallel track sessions
Pharmaceutical Procurement ? Room: Kivukoni 1-3 (Simultaneous French
translation available)
Co-moderators: Joseph Muhume and Anthony So
1.	Overview of Pooled Procurement Models
Andrew Barraclough, Management Sciences for Health/M&L, Indonesia
2.	Critical Success Factors for Pooled Procurement
Francis Burnett, OECS/PPS, St. Lucia
3.	Enhancing Access to Treatment for PLWHA in the ECSA Region: Activities of
the Commonwealth Regional Health Community
Bannet Ndyanabangi, CRHCS, Tanzania
4.	Lessons Learned from MSF Experience in ARV Procurement in Developing
Countries
Raffaella Ravinetto, Médecins sans Frontières, Spain
5.	Development and Testing of a Prequalification Procedure for HIV/AIDS, TB,
and Malaria Products and Manufacturers
Lembit Rägo, WHO/EDM
6.	Integration of Vertical Disease-Related Procurement Systems into
Mainstream Procurement Efforts
Christopher Msemo, Medical Stores Department, Tanzania

Human Resources for the Pharmaceutical Sector ? Room: Kivukoni 4
Co-moderators: G. Mliga and Douglas Keene
1.	Human Resources for the Pharmaceutical Sector: Issues, Challenges, and
Opportunities
Eva Ombaka, EPN, Kenya
2.	Employment Opportunities, Career Development, and Preventing ?Brain
 Drain?
Mabel Torongo, Zimbabwe
3.	Human Capacity Development as an Effective Response to HIV/AIDS: Human
Resources Implications of Scaling Up Care
Ummuro Adano, Management Sciences for Health/M&L, Kenya
4.	Using Best Practices to Improve Performance
Nina Pruyn, Advance Africa, U.S.A.
5.	Community-Based Training of Informal Drug Sellers to Improve Malaria Case
Management in Children under Five In Nigeria
George Greer, BASICS II, U.S.A.
6.	Using New Technology to Increase Productivity: The Role of PDAs in in the
Tanzania Quality Assurance Program
Arin Speed, Management Sciences for Health/CPM, U.S.A., and Mwemezi Ngemera,
Tanzanian Food and Drug Authority, Tanzania

3:30?4:00 p.m.
Coffee/Tea break

4:00?6:00 p.m.
Afternoon session #2
Small group discussions

Pharmaceutical Procurement

Group A ? Room: Marquee 1
Group B ? Room: Marquee 2
Group C ? Room: Tradewinds
Group D ? Room: Kivukoni 1-3
Human Resources for the Pharmaceutical Sector

Group A ? Room: Ruvu
Group B ? Room: Kivukoni 4
Group C ? Room: Marquee 3
Group D ? Room: Marquee 4

DAY 3?December 12, 2003

All Day
Posters and electronic demos on display
Author coverage during breaks

8:30?10:15 a.m.
Morning session #1
Parallel track sessions
Pharmaceutical Product Quality Assurance ? Room: Kivukoni 1-3 (Simultaneous
French translation available)
Co-moderators: Dr. N. B. Chukilizo and Marthe Everard
1.	Quality Assurance in Practice: Product Quality Standards and
Bioequivalence Issues
Thomas Layloff, Management Sciences for Health/SEAM, U.S.A.
2.	Registration, Inspection, and Testing: How to Prioritize
Souly Phanouvong, USP. U.S.A.
3.	GMP Compliant: To Be or Not to Be? Relative Risks of Noncompliance
a.	Regulatory Perspective
Charles Kandie, WHO/Kenya
b.	Procurement Perspective
Henk den Besten, International Dispensary Association, The Netherlands
4.	Minilabs as a Component of Quality Monitoring: Experiences and
Methodological Issues
Zera Msuya, Food and Drugs Authority, Tanzania

Pharmaceutical Product Prices ? Room: Kivukoni 4
Co-moderators: Zachary Berege and Abayneh Desta
1.	Policies That Promote Fair Pricing of Pharmaceuticals
Anthony So, The Rockefeller Foundation, U.S.A.
2.	Implementation of the Doha Declaration on TRIPS/Public Health: Overview
of Recent Developments and Actions Needed to Ensure That the Declaration
Impacts Procurement of Low-Priced Medicines
Sisule Musungu, Programme on International Trade & Development, South
Centre, Geneva, Switzerland
3.	Medicines: The Price People Pay
Margaret Ewen, HAI, The Netherlands
4.	A New Approach to Measuring Drug Prices: Results of the WHO/HAI Drug
Pricing Project?s South African Pilot Study
Aarti Patel, South Africa
5.	Factors Contributing to the Pricing of Pharmaceuticals in Tanzania
Mhina S. Chambuso, Muhimbili University College of Health Sciences, Tanzania

10:15?10:45 a.m.
Coffee/Tea break


10:45 a.m.?12:30 p.m.
Morning session #2
Small group discussions

Pharmaceutical Product Quality Assurance:
Group A ? Room: Marquee 1
Group B ? Room: Marquee 2
Group C ? Room: Tradewinds
Group D ? Room: Kivukoni 1-3

Pharmaceutical Product Prices:
Group A ? Room: Ruvu
Group B ? Room: Kivukoni 4
Group C ? Room: Marquee 3
Group D ? Room: Marquee 4


12:30 p.m.?1:30 p.m.
Lunch break

1:30?3:00 p.m.
Afternoon session #1
Moderator: Dr. Omar Makame Shauri
Plenary presentations ? Room: Kivukoni 1-3 (Simultaneous French translation
available)
·	Reports of parallel track topic discussion group
1.	Pharmaceutical Management and Supply Systems
2.	Rational Use of Medicines
3.	Pharmaceutical Procurement
4.	Human Resources for the Pharmaceutical Sector
·	Discussion

3:00?3:15 p.m.
Coffee/Tea break

3:15?4:30 p.m.
Afternoon session #2
Moderator: Dr. Omar Makame Shauri
Plenary presentations ? Room: Kivukoni 1-3 (Simultaneous French translation
available)
·	Reports of parallel track topic discussion groups (continued)
5.	Pharmaceutical Product Quality Assurance
6.	Pharmaceutical Product Prices
·	Discussion
·	Remarks by Representative from Ghana
·	Closing address
Honorable Anna Margareth Abdallah, Minister of Health, United Republic of
Tanzania
·	Closing remarks
Keith Johnson, Director, SEAM Program, Management Sciences for Health,
U.S.A.

**************

SEAM 2003 Conference
Parallel Track Sessions and Discussion Group Topics

For each of the following groupings, select one of the parallel track topics
shown. Then select one of the discussion group topics shown for each
parallel track you have chosen.

Grouping #1
Parallel Track Topics	Discussion Group Topics
Pharmaceutical Management and Supply Systems
      A?Requirements for successful management and supply systems
	B?Private sector approaches to improving access to care
	C?Alternatives to traditional public supply mechanisms
	D?Ensuring drug supply for HIV/AIDS
Rational Use of Medicines
      A?Strategies for improved drug lists and treatment guidelines and
adherence to them
	B?Role of community assessments
	C?Strategies for minimizing antimicrobial resistance
	D?Using regulation to improve rational drug use

Grouping #2
Parallel Track Topics	Discussion Group Topics
Pharmaceutical Procurement
      A?Regional pooled procurement
	B?Prequalification issues
	C?Ensuring access to patented products
	D?Integration of vertical disease-related procurement into mainstream
procurement
Human Resources for the Pharmaceutical Sector
      A?Preventing brain drain
	B?Using best practices to improve performance
	C?Staffing for responding to the HIV/AIDS crisis
	D?Using new technology and software

Grouping #3
Parallel Track Topics	Discussion Group Topics
Pharmaceutical Product Quality Assurance
      A?Quality assurance strategies for developing countries
	B?Testing as part of quality assurance programs
	C?Importance of Good Manufacturing Practice
	D?Quality of malaria products
Pharmaceutical Product Prices
      A?Drug price regulation
	B?Drug price reporting and monitoring
	C?Financing drug procurement
	D?What countries can do to decrease drug prices

Pour vous inscrire, vous désinscrire et consulter les archives de e-med :
http://www.essentialdrugs.org/emed/

--
Adresse pour les messages destinés au forum E-MED:
e-med@healthnet.org
Pour répondre à un message envoyer la réponse au forum
ou directement à l'auteur.
Pour toutes autres questions addresser vos messages à :
e-med-help@healthnet.org